platinum has been researched along with prasugrel hydrochloride in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, T; Garg, S; Ishibashi, Y; Kageyama, S; Katagiri, Y; Kawashima, H; Kogame, N; Kotoku, N; Kozuma, K; Masuda, S; Miyazaki, Y; Morino, Y; Muramatsu, T; Nakamura, M; Nakatani, S; Nakazawa, G; Ninomiya, K; Okamura, T; Onuma, Y; Ozaki, Y; Serruys, PW; Takahashi, H; Takahashi, K; Tanabe, K; Tateishi, H; Tu, S | 1 |
1 other study(ies) available for platinum and prasugrel hydrochloride
| Article | Year |
|---|---|
Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN).
Topics: Aspirin; Drug-Eluting Stents; East Asian People; Everolimus; Hemorrhage; Humans; Japan; Percutaneous Coronary Intervention; Pilot Projects; Platinum; Polymers; Prasugrel Hydrochloride; Prospective Studies | 2023 |